Benjamin Harshbarger - Jun 8, 2021 Form 4 Insider Report for CATABASIS PHARMACEUTICALS INC (ATXS)

Role
Chief Legal Officer
Signature
/s/ Benjamin Harshbarger
Stock symbol
ATXS
Transactions as of
Jun 8, 2021
Transactions value $
$0
Form type
4
Date filed
6/10/2021, 04:06 PM
Previous filing
Jun 2, 2021
Next filing
Mar 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATXS Stock Option (right to buy) Award $0 +200K $0.00 200K Jun 8, 2021 Common Stock 200K $2.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of June 8, 2021 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.